Category: Depression

For Your Consideration: Tips for Assessing and Treating Clinical Depression

For Your Consideration: Tips for Assessing and Treating Clinical Depression

Think of depression not as a diagnosis, but instead as a cluster of symptoms with many possible causes. Possible causes of clinical depression: Psychosocial stressors. Often referred to as reactive depression, individuals have difficulty adjusting to troublesome environmental stimuli such as a recent divorce, job loss or the death of a family member or close [...]

Frequently Asked Questions

Q. When diagnosing depression in a client, how concerned should I be about identifying specific depression subtypes? Do specific subtypes suggest different treatment modalities? A. For years now, clinicians have attempted to categorize depressions into “subtypes.” A few examples are: typical vs. atypical, reactive vs. biological and psychotic vs. non-psychotic. There are as many as [...]

Frequently Asked Questions Regarding Risk Factors for Developing Depression

Frequently Asked Questions Regarding Risk Factors for Developing Depression

What are some of the biggest risk factors for developing depression? The three biggest risk factors for developing depression are: (1) Genetic predisposition. Many individuals that meet criteria for major depressive disorder have a significant family history for depression. Treating clinicians should always thoroughly examine the depressed client’s “family tree” for depression. (2) Environmental events. [...]

What to do when your Partner is depressed

What to do when your Partner is depressed

- It is important that the non-depressed partner realize that depression can be selfish and manipulative. Depressed partners build a safety net around themselves. They will grant their non-depressed partner access to their cocoon-like existence when they’re up to it, but will often inappropriately rebuff the partner at other times. The important issue here is [...]

Non-Pharmacological Options for Managing Depression: What the Pharmaceutical Companies Will Never Tell You

Non-Pharmacological Options for Managing Depression: What the Pharmaceutical Companies Will Never Tell You

- Bright light exposure represents a proven strategy for managing depression. Light receptors in the retina connect to circuits in the brain that regulate circadian rhythm. Sunlight is the prime stimulator of the eyes’ photoreceptors: it triggers a cascade of neurochemical reactions that aid in keeping the “body clock” in synch. Regular bright light exposure [...]

Depression in Older Men

Depression in Older Men

- Six million men suffer from depression each year. Older men with depression tend to live in an “emotional vacuum” by socially isolating themselves and comforting their depression through the use of alcohol. Older men who have never married and men that have lost their spouses are most vulnerable.   – Evidence indicates that testosterone [...]

Three Common Reasons People Give for NOT Seeking Treatment for Depression

Three Common Reasons People Give for NOT Seeking Treatment for Depression

1.  One reason people give for not seeking treatment for depression is that this is the type of thing one just rides out. They believe they will just “snap out” of the depression or that they can “will” it away. They convince themselves that their depression will disappear if they read just one more self-help [...]

New Indications for Symbyax

Eli Lilly has gained FDA approval for its combination psychotropic medication product Symbyax to be used in the management of treatment-resistant depression. Symbyax was previously approved only for the treatment of depressive episodes associated with bipolar disorder. The drug is a combination of the antipsychotic Zyprexa (olanzapine) with the antidepressant Prozac (fluoxetine) and is now [...]

Pristiq: New Antidepressant or Merely a Patent Extender?

The newest entry into the antidepressant market is Pristiq (desvenlafaxine).Pristiq (desvenlafaxine), is in the SNRI category of antidepressants and is manufactured by the Wyeth Corporation. This drug received FDA approval in March, 2008. Faced with the fact that Wyeth is losing patent protection for its top-selling antidepressant Effexor XR(venlafaxine XR), the company needed a brand [...]